Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience

High-grade epithelial ovarian cancer (HG-EOC) is the most lethal gynecologic malignancy worldwide Once patients develop chemoresistance, effective novel strategies are required to improve prognosis We analyzed characteristics and outcomes of 242 consecutive patients with HG-EOC participating in 94 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Ming-Mo, Wang, Zhijie, Janku, Filip, Piha-Paul, Sarina, Naing, Aung, Hong, David, Westin, Shannon, Coleman, Robert L., Sood, Anil K., Tsimberidou, Apostolia M., Subbiah, Vivek, Wheler, Jennifer, Zinner, Ralph, Lu, Karen, Meric-Bernstam, Funda, Fu, Siqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085215/
https://www.ncbi.nlm.nih.gov/pubmed/27147567
http://dx.doi.org/10.18632/oncotarget.9048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085215/
https://www.ncbi.nlm.nih.gov/pubmed/27147567
http://dx.doi.org/10.18632/oncotarget.9048

Ejemplares similares